Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01XOther antineoplastic agents
- Chemical subgroupL01XX
- Chemical substanceL01XX19
Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Irinotecan equ irinotecan
Every register, a page at a time. Strengths and packs are on each medicine’s page.
12 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Irinotecan Kabi | Italy | Soluzione per infusione | Authorised | Fresenius Kabi Italia S.R.L. | |
| Irinotecan Accord | Italy | Concentrato per soluzione per infusione | Authorised | Accord Healthcare, S.L.U. | |
| Irinotecan Kabi | Serbia | 40mg/2mL | koncentrat za rastvor za infuziju | Authorised | Fresenius Kabi D.O.O. Beograd |
| Irinotecan Kabi | Serbia | 100mg/5mL | koncentrat za rastvor za infuziju | Authorised | Fresenius Kabi D.O.O. Beograd |
| Irinotecan Accord | Serbia | 20mg/mL | koncentrat za rastvor za infuziju | Authorised | Evropa Lek Pharma D.O.O. Beograd |
| Irinotecan Accord | Serbia | 20mg/mL | koncentrat za rastvor za infuziju | Authorised | Evropa Lek Pharma D.O.O. Beograd |
| Irinotecan Accord | Serbia | 20mg/mL | koncentrat za rastvor za infuziju | Authorised | Evropa Lek Pharma D.O.O. Beograd |
| Irinotecan Accord | Serbia | 20mg/mL | koncentrat za rastvor za infuziju | Authorised | Evropa Lek Pharma D.O.O. Beograd |
| Irinotecan-Rex | New Zealand | Inj 20 mg per ml, 5 ml vial | Funded | ||
| Irinotecan | Canada | 20 MG / ML | Solution | Cancelled | Pfizer Canada Ulc |
| IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40mg/2ml | Singapore | 40mg/vial | infusion, solution concentrate | Authorised | Tranet Holdings Pte LTD |
| IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 100mg/5ml | Singapore | 100mg/vial | infusion, solution concentrate | Authorised | Tranet Holdings Pte LTD |